Nina Kjellson

General Partner at Canaan Management, Inc.

Nina Kjellson

Nina Kjellson

General Partner at Canaan Management, Inc.

Overview
Career Highlights

ConsumerMed.Org

RelSci Relationships

1838

Number of Boards

36

Birthday

1974

Age

45

Contact Data
Trying to get in touch with Nina Kjellson? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Nina Kjellson likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Partner at Sofinnova Ventures, Inc.

Relationship likelihood: Strong

General Partner at Interwest Venture Management Co.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Welltok, Inc.

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Executive Partner, Private Equity at Sofinnova Ventures, Inc.

Relationship likelihood: Strong

Professional at Interwest Venture Management Co.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Dauntless Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Partner, Private Equity at Sofinnova Ventures, Inc.

Relationship likelihood: Strong

Co-Founder at Altair Therapeutics, Inc.

Relationship likelihood: Strong

Executive Officer at Milestone Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Nina Kjellson
Potential Connections via
Relationship Science
You
Nina Kjellson
General Partner at Canaan Management, Inc.
Education
BA Human Biology
Class of 1997

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Career History
General Partner
2015 - Current

Canaan Management focuses on investments primarily in the technology and healthcare sectors. In the technology sector, the firm focuses on digital media, communications, mobility, enterprise software and clean technology. Within the healthcare sector, Canaan Partners focuses on investments in biopharmaceuticals, medical devices and diagnostics. Canaan Partners also invests technology-based Indian companies in the following sectors: consumer Internet, digital media, mobile and enterprise and managed services. In Israel, the firm seeks to invest in the development of early-stage companies in the following areas: (1) consumer Internet and digital media (2) communications infrastructure (3) enterprise software (4) clean technology and (5) medical device technologies.

Co-Chairman
Current

ConsumerMed is a medical organization that specializes in baby boomers.

General Partner
2002 - 2015

InterWest Partners focuses on early-stage investments in life sciences and information technology companies. Within the life sciences sector, the firm invests in a range of early-stage opportunities including the funding of preclinical companies with great potential. They also consider investing in or starting new companies around clinical or commercial stage assets. Within the information technology sector, InterWest looks for early-stage companies with near-term ROI-based value propositions. They favor investments in development-stage companies. Investments average $10 million to $15 million over the life of a company. InterWest serves as the lead investor in the majority of their investments.

Boards & Committees
Member, Board of Observers
Current

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Member, Board of Observers
Current

InterWest Partners focuses on early-stage investments in life sciences and information technology companies. Within the life sciences sector, the firm invests in a range of early-stage opportunities including the funding of preclinical companies with great potential. They also consider investing in or starting new companies around clinical or commercial stage assets. Within the information technology sector, InterWest looks for early-stage companies with near-term ROI-based value propositions. They favor investments in development-stage companies. Investments average $10 million to $15 million over the life of a company. InterWest serves as the lead investor in the majority of their investments.

Director
Current

Primera Diagnostics, Inc. provides medical and diagnostics equipment and services. The company is headquartered in Providence, RI

Co-Chairman
Current

ConsumerMed is a medical organization that specializes in baby boomers.

Director
Current

Essential Access Health provides family healthcare services. Its services include clinic support initiatives, advanced clinical research, provider training, patient education, advocacy, and consumer awareness. The company was founded in 1968 and is headquartered in Los Angeles, CA.

Political Donations
$1,004
2012
$1,004
2011
$972
2010
Transactions
Details Hidden

Celladon Corp. purchases Eiger BioPharmaceuticals, Inc. (Inactive) from Vivo Capital LLC, InterWest Partners, LLC resulting in a new company Eiger BioPharmaceuticals, Inc.

Details Hidden

Ocera Therapeutics, Inc. purchases Ocera Therapeutics, Inc. (Inactive) from Sofinnova Ventures, Inc., Domain Associates LLC, InterWest Partners, LLC, Thomas McNerney Ptn

Events
Attendee
New York City, NY
2012 Forbes Healthcare Summit

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nina Kjellson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nina Kjellson's profile does not indicate a business or promotional relationship of any kind between RelSci and Nina Kjellson.